GOLDMAN SACHS & CO. LLC 13D and 13G filings for ProQR Therapeutics N.V.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
2021-02-12 1:02 pm Purchase | 2020-12-31 | 13G | ProQR Therapeutics N.V. PRQR | GOLDMAN SACHS & CO. LLC | 3,297,270 6.600% | 3,297,270![]() (New Position) | Filing |